Source: FinanzNachrichten

ChemPartner: ChemPartner Makes Additional Investments in Biologics from Research to Manufacturing Capabilities

SHANGHAI, June 10, 2020 /PRNewswire/ -- Shanghai ChemPartner announced the additional investments the company is making into its biologics business unit to further its capabilities and capacity in...

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
CEO Avatar

CEO

Wei Tang

CEO Approval Rating

84/100

Read more